Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vaxart, Inc. - Common Stock (NQ:VXRT)

0.5080 +0.0082 (+1.64%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vaxart, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Vaxart Is Gaining Relevance, But Its Future Is Still Uncertain
Vaxart may have a second chance at prominence with its Covid-19 vaccine pill. But VXRT stock is still a largely speculative buy. 
Via InvestorPlace
Exposures COVID-19
Why Shares of Vaxart Jumped 31.2% in the First Half of 2021
The first half has been a cycle of hope and disappointment for shareholders. 
Via The Motley Fool
Why Coronavirus Stocks Are Zooming Higher Today
The surge in cases and deaths could significantly ramp up demand for these companies' existing and pipeline products. 
Via The Motley Fool
Topics Death
Exposures COVID-19 Death
3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street
Analysts' high-water price targets imply some serious gains for these companies. 
Via The Motley Fool
Topics Economy
Exposures COVID-19 Economy
Why Vaxart Shares Are Trading Higher Today
Vaxart Inc (NASDAQ:VXRT) shares are trading higher by 30% ... 
Via Benzinga
Don’t Count on a Covid-19 Boost for Vaxart
VXRT stock remains a speculative bet as the company's chance to develop an oral Covid-19 vaccine grows slimmer every day. 
Via InvestorPlace
Exposures COVID-19
New Developments Have Made Vaxart Stock So Much More Attractive
Vaxart recently made a licensing deal, and two research firms issued upbeat assessments of the company, making me more upbeat on VXRT stock. 
Via InvestorPlace
Exposures COVID-19
Watch Out for a Selloff in Vaxart Stock
VXRT stock's price may drop as their oral inoculation waits in the wings while other vaccine manufacturers take over the market. 
Via InvestorPlace
Exposures COVID-19
Vaxart Inks Antiviral Asset Licensing Pact With Altesa Biosciences
Vaxart Inc (NASDAQ: VXRT) has granted Altesa Biosciences Inc an exclusive worldwide license to develop and commercialize Vaxart's patented... 
Via Benzinga
Vaxart Stock Could Make Another Big Return in the Future
It might be tempting to dismiss VXRT stock now that other Covid-19 vaccines are available, but pill-based vaccines for diseases are appealing. 
Via InvestorPlace
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2021
Upgrades For Taiwan Semiconductor Manufacturing Co Ltd (NYSE: 
Via Benzinga
Will the Promise of Avoiding the Needle Pay Off for Vaxart?
VXRT stock just received a buy recommendation and a $13 price target from Jefferies, based on the promise of a oral vaccine instead of a needle. 
Via InvestorPlace
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021
Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE: 
Via Benzinga
Is Now The Time To Buy Stock Or Options In Apple, PayPal, Square Or Vaxart?
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... 
Via Benzinga
VXRT Stock: Can Redditors Help Vaxart Power Higher?
Today, VXRT stock is climbing higher on an otherwise red day for the markets, as many speculate retail investors could be behind this rise. 
Via InvestorPlace
Vaxart Is Still Not Worth Anywhere Near Its Present Price
Vaxart is still not worth today's price. VXRT stock is worth no more than $6, especially if it's going to need another capital raise. 
Via InvestorPlace
Exposures COVID-19
Why COVID Vaccine Stocks Dynavax, Novavax, and Vaxart Are Sinking Today
The declines appear to be caused simply by volatility that's common with small biotech stocks. 
Via The Motley Fool
Exposures COVID-19
Is It Too Late to Buy Vaxart Stock?
The science looks fishy for this small-cap biotech. 
Via The Motley Fool
Exposures COVID-19
Meme Stocks Continue To Surge As Traders Move To Biotech
The meme stock crowd turned its attention to biotech and healthcare stocks, boosting some shares by as much as 10%. 
Via Talk Markets
64 Biggest Movers From Friday
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
VXRT Stock: Why Redditors Are Betting on a Big Squeeze With Vaxart Today
VXRT stock is on the move as the company received some very bullish coverage from an analyst initiating coverage today. 
Via InvestorPlace
Most Active Equity Options For Midday - Friday, June 11
Top tickers for midday: AMC, AAPL, TSLA, NIO, NVDA, AMZN, CLOV, SNAP, CLF, GME, PLTR, VXRT, AMD, MO, F, SENS, BAC, MSFT, BB, ET. 
Via Talk Markets
Nasdaq, S&P 500 Eye Weekly Wins as Bond Yields Retreat
The 10-year Treasury bond yield fell to a three-month low. 
Via Talk Markets
Topics Bonds Stocks
Exposures Debt Markets US Equities
46 Stocks Moving In Friday's Mid-Day Session
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,... 
Via Benzinga
Why Vaxart Stock Is Skyrocketing Today
Investors are cheering an analyst's positive recommendation. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to... 
Via Benzinga
Why Shares of Vaxart Plummeted 38.6% in May
This isn't the first time its coronavirus vaccine pill has disappointed investors. 
Via The Motley Fool
Exposures COVID-19
Bet on a No-Needle Vaccine Strategy with Vaxart
Reimagining Covid-19 vaccines isn't an easy task, but Vaxart is prepared to innovate - and VXRT stock could move higher at any given moment. 
Via InvestorPlace
Exposures COVID-19
10 More Current & Former Penny Stocks With High Short Interest
High Short Interest Stocks Are Something Traders Are On The Hunt For & Here's Another 10 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS